Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Original Articles

Obesity exacerbates ischemia-reperfusion injury and senescence in murine kidneys and perirenal adipose tissues: Seo Rin Kim, Young-Suk Kim, Je Min Hyeon et al.; Received August 25, 2022 Accepted February 3, 2023 Published online March 7, 2024; [Epub ahead of print]; Full text PubReader ePub PDF Supplementary Material

Adipose tissue-derived mesenchymal stromal cells for treating chronic kidney disease: A pilot study assessing safety and clinical feasibility: Sandra Villanueva, Fernando González, Eduardo Lorca et al.; Kidney Res Clin Pract. 2019;38(2):176-185. Published online June 30, 2019; DOI: https://doi.org/10.23876/j.krcp.18.0139
Web of Science 13 Cited By 16; Full text PubReader PDF Supplementary Material

Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants: Seung Seok Han, Do Hyoung Kim, Su Mi Lee et al.; Kidney Res Clin Pract. 2012;31(3):157-162. Published online June 26, 2012; DOI: https://doi.org/10.1016/j.krcp.2012.06.007
Cited By 18; Full text PubReader PDF

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

15,095	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
20,010	C4d Puzzle in ABO-incompatible kidney transplantation
8,515	How should we treat acute kidney injury caused by renal congestion?
13,238	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
35,336	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 15	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.